BVS
Bioventus Inc
12.90$
+2.2%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 30.7% | 29.3% | 33.3% | 31.5% | 26.4% | 26.7% | 27.3% | 29.7% | 35.4% | 35.9% | 32.3% | 32.7% | |
| 69.3% | 70.7% | 66.7% | 68.5% | 73.6% | 73.3% | 72.7% | 70.3% | 64.6% | 64.1% | 67.7% | 67.3% | |
| 3.9% | 5.8% | 2.9% | 2.8% | 2.5% | 3.3% | 3.5% | 4.4% | 4.7% | 2.6% | 2.4% | 2.1% | |
| – | – | – | – | 60.1% | 57.7% | 59.3% | 58.1% | 63.8% | 58.6% | 56.3% | 55.3% | |
| 68.1% | 68.5% | 61.3% | 59.2% | 65.6% | 64.1% | 66.1% | 67.5% | 97.3% | 80.0% | 69.8% | 57.0% | |
| 0.0% | -6.5% | 5.4% | 9.3% | 8.0% | 9.2% | 6.6% | 2.8% | -32.7% | -16.0% | -2.1% | 10.3% | |
| 4.9% | 5.6% | 5.8% | 6.5% | 6.0% | 6.3% | 3.0% | 0.3% | 2.3% | 7.9% | 6.8% | 4.7% | |
| -4.7% | -12.6% | -2.1% | 3.0% | 1.9% | 2.8% | 5.0% | 2.2% | -36.9% | -23.6% | -8.6% | 4.5% | |
| 0.6% | 0.8% | 0.4% | -0.3% | 0.5% | 0.5% | 0.4% | -0.5% | -8.7% | 0.0% | -0.9% | -0.3% | |
| -5.3% | -13.4% | -6.5% | -0.6% | -3.8% | 2.0% | 5.1% | 4.5% | -31.0% | -30.5% | -5.9% | 4.0% | |
| 12.1% | 15.2% | 16.0% | 20.5% | 17.1% | 18.1% | 16.9% | 10.6% | -23.7% | -4.5% | 6.8% | 17.5% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.